How can PubChem be leveraged for neglected and rare disease drug discovery?

被引：0
|
作者：
Bolton, Evan [1 ]
机构：
[1] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 247卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
28-CINF
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Collaborative drug discovery and structural genomics: Positive impact for neglected disease research
    Edwards, Aled
    Hui, Raymond
    Sacchettini, James
    Wernimont, Amy
    Brown, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [42] Anti-leishmanial Drug Discovery: Rising to the Challenges of a Highly Neglected Disease
    Sharlow, Elizabeth R.
    Groegl, Max
    Johnson, Jacob
    Lazo, John S.
    MOLECULAR INTERVENTIONS, 2010, 10 (02) : 72 - 75
  • [43] Neglected infectious disease case studies and implications for commercial collaborative drug discovery
    Bunin, Barry A.
    Ekins, Sean
    Hohman, Moses
    Ernst, Sylvia
    Gregory, Kellan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [44] OpenEye Award: Public domain chemical databases for neglected disease drug discovery
    Nicola, George
    Liu, Tiqing
    Gilson, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [45] PubChem and PubChem3D: Public chemical information resources for biological assay data analysis and drug discovery
    Kim, Sunghwan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [46] Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
    Jonathan Cechetto
    Hee Kyoung Jeon
    Jiyeon Jang
    Doyoon Kwon
    Thierry Christophe
    Priscille Brodin
    Gyongseon Yang
    Jair Neto
    Lucio Freitas Junior
    BMC Proceedings, 5 (Suppl 1)
  • [47] Drug discovery and development for neglected parasitic diseases
    Renslo, Adam R.
    McKerrow, James H.
    NATURE CHEMICAL BIOLOGY, 2006, 2 (12) : 701 - 710
  • [48] Neglected Aspects of Drug Discovery - Microbiological Aspects
    Golenser, Jacob
    Hunt, Nicholas
    CURRENT CLINICAL PHARMACOLOGY, 2013, 8 (01): : 73 - 80
  • [49] Phenomic technologies in drug discovery of neglected diseases
    Ulf Nehrbass
    BMC Proceedings, 5 (Suppl 1)
  • [50] Drug discovery and development for neglected parasitic diseases
    Adam R Renslo
    James H McKerrow
    Nature Chemical Biology, 2006, 2 : 701 - 710
12345